Journey Medical Corporation beat EPS estimates 67% of the time across 3 reported quarters (2 beats, 1 misses), averaging +6.3% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $-0.01 | $-0.01 | +0.0% | Beat | Q2 FY26 call |
| Q1 FY26 | $-0.07 | $-0.08 | -14.3% | Miss | Q1 FY26 call |
| Q4 FY25 | $-0.06 | $-0.04 | +33.3% | Beat |
Back to DERM overview · DERM holders · DERM KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.